408 related articles for article (PubMed ID: 7568024)
1. Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31.
Lee-Huang S; Huang PL; Huang PL; Bourinbaiar AS; Chen HC; Kung HF
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8818-22. PubMed ID: 7568024
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus type 1 (HIV-1) inhibition, DNA-binding, RNA-binding, and ribosome inactivation activities in the N-terminal segments of the plant anti-HIV protein GAP31.
Lee-Huang S; Kung HF; Huang PL; Bourinbaiar AS; Morell JL; Brown JH; Huang PL; Tsai WP; Chen AY; Huang HI
Proc Natl Acad Sci U S A; 1994 Dec; 91(25):12208-12. PubMed ID: 7527556
[TBL] [Abstract][Full Text] [Related]
3. Anti-HIV and anti-tumor activities of recombinant MAP30 from bitter melon.
Lee-Huang S; Huang PL; Chen HC; Huang PL; Bourinbaiar A; Huang HI; Kung HF
Gene; 1995 Aug; 161(2):151-6. PubMed ID: 7665070
[TBL] [Abstract][Full Text] [Related]
4. The antiviral agents, MAP30 and GAP31, are not toxic to human spermatozoa and may be useful in preventing the sexual transmission of human immunodeficiency virus type 1.
Schreiber CA; Wan L; Sun Y; Lu L; Krey LC; Lee-Huang S
Fertil Steril; 1999 Oct; 72(4):686-90. PubMed ID: 10521111
[TBL] [Abstract][Full Text] [Related]
5. The activity of plant-derived antiretroviral proteins MAP30 and GAP31 against herpes simplex virus in vitro.
Bourinbaiar AS; Lee-Huang S
Biochem Biophys Res Commun; 1996 Feb; 219(3):923-9. PubMed ID: 8645280
[TBL] [Abstract][Full Text] [Related]
6. Proteolytic fragments of anti-HIV and anti-tumor proteins MAP30 and GAP31 are biologically active.
Huang PL; Sun Y; Chen HC; Kung HF; Lee-Huang S
Biochem Biophys Res Commun; 1999 Sep; 262(3):615-23. PubMed ID: 10471373
[TBL] [Abstract][Full Text] [Related]
7. Production of antiviral and antitumor proteins MAP30 and GAP31 in cucurbits using the plant virus vector ZYMV-AGII.
Arazi T; Lee Huang P; Huang PL; Zhang L; Moshe Shiboleth Y; Gal-On A; Lee-Huang S
Biochem Biophys Res Commun; 2002 Mar; 292(2):441-8. PubMed ID: 11906182
[TBL] [Abstract][Full Text] [Related]
8. A new activity of anti-HIV and anti-tumor protein GAP31: DNA adenosine glycosidase--structural and modeling insight into its functions.
Li HG; Huang PL; Zhang D; Sun Y; Chen HC; Zhang J; Huang PL; Kong XP; Lee-Huang S
Biochem Biophys Res Commun; 2010 Jan; 391(1):340-5. PubMed ID: 19913503
[TBL] [Abstract][Full Text] [Related]
9. Both substrate and target oligonucleotide sequences affect in vitro integration mediated by human immunodeficiency virus type 1 integrase protein produced in Saccharomyces cerevisiae.
Leavitt AD; Rose RB; Varmus HE
J Virol; 1992 Apr; 66(4):2359-68. PubMed ID: 1548767
[TBL] [Abstract][Full Text] [Related]
10. Effects of tyrphostins, protein kinase inhibitors, on human immunodeficiency virus type 1 integrase.
Mazumder A; Gazit A; Levitzki A; Nicklaus M; Yung J; Kohlhagen G; Pommier Y
Biochemistry; 1995 Nov; 34(46):15111-22. PubMed ID: 7578125
[TBL] [Abstract][Full Text] [Related]
11. Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease.
Mazumder A; Wang S; Neamati N; Nicklaus M; Sunder S; Chen J; Milne GW; Rice WG; Burke TR; Pommier Y
J Med Chem; 1996 Jun; 39(13):2472-81. PubMed ID: 8691444
[TBL] [Abstract][Full Text] [Related]
12. Juxtaposition of two viral DNA ends in a bimolecular disintegration reaction mediated by multimers of human immunodeficiency virus type 1 or murine leukemia virus integrase.
Chow SA; Brown PO
J Virol; 1994 Dec; 68(12):7869-78. PubMed ID: 7966577
[TBL] [Abstract][Full Text] [Related]
13. Quantitative in vitro assay for human immunodeficiency virus deoxyribonucleic acid integration.
Carteau S; Mouscadet JF; Goulaouic H; Subra F; Auclair C
Arch Biochem Biophys; 1993 Feb; 300(2):756-60. PubMed ID: 8434953
[TBL] [Abstract][Full Text] [Related]
14. Substrate features important for recognition and catalysis by human immunodeficiency virus type 1 integrase identified by using novel DNA substrates.
Chow SA; Brown PO
J Virol; 1994 Jun; 68(6):3896-907. PubMed ID: 8189526
[TBL] [Abstract][Full Text] [Related]
15. The role of manganese in promoting multimerization and assembly of human immunodeficiency virus type 1 integrase as a catalytically active complex on immobilized long terminal repeat substrates.
Wolfe AL; Felock PJ; Hastings JC; Blau CU; Hazuda DJ
J Virol; 1996 Mar; 70(3):1424-32. PubMed ID: 8627659
[TBL] [Abstract][Full Text] [Related]
16. Effect of topoisomerase inhibitors on the in vitro HIV DNA integration reaction.
Carteau S; Mouscadet JF; Goulaouic H; Subra F; Auclair C
Biochem Biophys Res Commun; 1993 May; 192(3):1409-14. PubMed ID: 8389550
[TBL] [Abstract][Full Text] [Related]
17. Processing of deoxyuridine mismatches and abasic sites by human immunodeficiency virus type-1 integrase.
Mazumder A; Pommier Y
Nucleic Acids Res; 1995 Aug; 23(15):2865-71. PubMed ID: 7659508
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of MDA-MB-231 human breast tumor xenografts and HER2 expression by anti-tumor agents GAP31 and MAP30.
Lee-Huang S; Huang PL; Sun Y; Chen HC; Kung HF; Huang PL; Murphy WJ
Anticancer Res; 2000; 20(2A):653-9. PubMed ID: 10810336
[TBL] [Abstract][Full Text] [Related]
19. Triplex-mediated inhibition of HIV DNA integration in vitro.
Mouscadet JF; Carteau S; Goulaouic H; Subra F; Auclair C
J Biol Chem; 1994 Aug; 269(34):21635-8. PubMed ID: 8063805
[TBL] [Abstract][Full Text] [Related]
20. The N-terminal region of HIV-1 integrase is required for integration activity, but not for DNA-binding.
Schauer M; Billich A
Biochem Biophys Res Commun; 1992 Jun; 185(3):874-80. PubMed ID: 1627142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
